Susan Rowinski, MSE
President and CEO
Susan has 26 years of combined industry operating and consulting experience in developing and selling new medical technologies. Her combined experience spans the entire company life cycle and includes advancing companies through fundraising, product development and launch and into sales.
Prior to starting Rowinski Group LLC, Susan’s industry responsibilities included, raising venture capital, managing strategic corporate partners, securing payer approvals, overseeing three worldwide introductions, and sales quota responsibility for five western U.S. states.
She held industry management positions with increasing responsibility included, Vice President, Marketing (PharmaSonics; Sunnyvale, California.), Director of Marketing (Cardiometrics; Mountain View, California.), Global Marketing Manager (Medtronic Vascular; San Diego, California), Product Manager (Quinton Instrument Company; Seattle, Washington.), Echocardiography Sales Representative (Advanced Technology Labs (ATL); Seattle, Washington.
Ms. Rowinski is an advisor to boards and accelerators. She served for six years (2013-2018) as a board member on the Purdue University Weldon Biomedical Advisory Board. Since 2009 Susan has been an advisor on reimbursement strategy and planning to LARTA under the National Institutes of Health (NIH) Commercialization Accelerator Program. She has been an advisor on reimbursement strategy and planning to the San Jose BioCenter (San Jose, California) and the Astia Accelerator (San Francisco, California).
Susan holds a Master of Science in Engineering from the University of Washington (Seattle, Washington). She was a recipient of the Young Women in Science and the U.S. Navy Scholarships. Susan has a Bachelor of Science in Health Physics from Purdue University (West Lafayette, Indiana). While at Purdue she earned the Designated Student Award and was a member of the Eta Sigma Gamma Health Physics Honorary Society
Susan is a current member of the teaching faculty at the University of Michigan. Master of Engineering program (MSE) and Georgia Institute of Technology. Master of BioMedical Innovation and Development (MBID). Her teaching focus is adding commercial value to medical technologies under development in academic centers and reducing business risks during the academic to commercial market transition. She was a member of the teaching faculty 2013-2019 for the Master of Translational Medicine program (MTM) at the University of California- San Francisco. To date she has taught over (900) PhD and Master level students.
In addition to her teaching work, Ms. Rowinski is an internationally recognized speaker on reimbursement and monetization strategy and implementation.